基本信息
浏览量:385
职业迁徙
个人简介
Professor Jason Roberts is a NHMRC Practitioner Fellow at The University of Queensland, Consultant Clinical Pharmacist at the Royal Brisbane and Women’s Hospital. He is Director of the NHMRC-funded Centre for Research Excellence REDUCE which is based at the University of Queensland Centre for Clinical Research. He serves as Research Chair of UQCCR aand is the Infectious Diseases Theme LEader at UQCCR. He is a clinician-scientist with a strong interest in research and his principal research theme is optimization of antibiotic dosing in the critically ill. Prof Roberts has published over 450 published papers and book chapters on this topic, has been awarded over $30 million in grants and (co)supervises 22 higher research degree students.
Prof Roberts was recognised as Australia’s leading researcher in two separate categories, Critical care and Communicable Diseases, by the Australian’s 2019 Research Magazine.
He has been invited to present his results at major international conferences in critical care, infectious diseases, pharmacy, nephrology, transplant and safety. He has served on the Critical Review Panel for ATS/IDSA Guidelines of HAP, HCAP and VAP and the Australian Therapeutic Guidelines - Antibiotic and the 2021 Surviving Sepsis Guidelines. He is the Past Chair of the Working Group for Antimicrobial Use in ICU for the European Society of Intensive Care Medicine and an Executive Member of the PK/PD Group (EPASG) within the European Society for Clinical Microbiology and Infectious Diseases (ESCMID).
He is Section Editor for the International Journal of Antimicrobial Agents and an Associate Editor of the Journal or Pharmacy Practice and Research, the journal for the Society of Hospital Pharmacists of Australia and an Associate Editor for Pharmacotherapy and Aanesthesiology Pain and Critical Care Medicine journal. He has convened >20 seminars/conferences including being co-convenor for Medicines Management 2013, The National Conference for Society of Hospital Pharmacists of Australia.
He also engages with Industry to perform studies that develop optimised antibiotic dosing regimens that maximise antibiotic efficacy for testing in clinical trials or for use in special patient patient populations (e.g. critically ill, pneumonia, dialysis).
He has a strong interest in clinical and research mentoring and enjoys the opportunity to interact with many like-minded people to share ideas on how to best treat infections in difficult-to-treat patients like the critically ill.
Jason’s research skills lie in study design and analysis, including clinical trials.
He has a specific interest in population pharmacokinetic modelling and pharmacokinetic/pharmacodynamic modelling.
Qualifications
Fellowship of the Society of Hospital Pharmacists, SHPA
Bachelor of Pharmacy with Honours Class 1, The University of Sydney
Doctor of Philosophy, The University of Queensland
Prof Roberts was recognised as Australia’s leading researcher in two separate categories, Critical care and Communicable Diseases, by the Australian’s 2019 Research Magazine.
He has been invited to present his results at major international conferences in critical care, infectious diseases, pharmacy, nephrology, transplant and safety. He has served on the Critical Review Panel for ATS/IDSA Guidelines of HAP, HCAP and VAP and the Australian Therapeutic Guidelines - Antibiotic and the 2021 Surviving Sepsis Guidelines. He is the Past Chair of the Working Group for Antimicrobial Use in ICU for the European Society of Intensive Care Medicine and an Executive Member of the PK/PD Group (EPASG) within the European Society for Clinical Microbiology and Infectious Diseases (ESCMID).
He is Section Editor for the International Journal of Antimicrobial Agents and an Associate Editor of the Journal or Pharmacy Practice and Research, the journal for the Society of Hospital Pharmacists of Australia and an Associate Editor for Pharmacotherapy and Aanesthesiology Pain and Critical Care Medicine journal. He has convened >20 seminars/conferences including being co-convenor for Medicines Management 2013, The National Conference for Society of Hospital Pharmacists of Australia.
He also engages with Industry to perform studies that develop optimised antibiotic dosing regimens that maximise antibiotic efficacy for testing in clinical trials or for use in special patient patient populations (e.g. critically ill, pneumonia, dialysis).
He has a strong interest in clinical and research mentoring and enjoys the opportunity to interact with many like-minded people to share ideas on how to best treat infections in difficult-to-treat patients like the critically ill.
Jason’s research skills lie in study design and analysis, including clinical trials.
He has a specific interest in population pharmacokinetic modelling and pharmacokinetic/pharmacodynamic modelling.
Qualifications
Fellowship of the Society of Hospital Pharmacists, SHPA
Bachelor of Pharmacy with Honours Class 1, The University of Sydney
Doctor of Philosophy, The University of Queensland
研究兴趣
论文共 999 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
The Journal of antimicrobial chemotherapy (2024)
Linda Earnest, Daniel Fernandez Ruiz,Melissa A. Edeling, Julio M. Carrera, Ashley Huey Yiing Yap,Chinn Yi Wong,Lauren E. Holz,Stephanie Gras,James P. Cooney,Kathryn C. Davidson,Samantha Grimley,Damian Purcell,
crossref(2024)
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2024)
MICROBIOLOGY SPECTRUMno. 2 (2024): e0306523-e0306523
Ming G. Chai, Quyen Tu, Menino O. Cotta,Michelle J. Bauer,Ross Balch, Charles Okafor,Tracy Comans,Peter Kruger,Jason Meyer,Kiran Shekar,Kara Brady,Cheryl Fourie,
Intensive Care Medicinepp.1-1, (2024)
NEPHROLOGYno. 2 (2024): 100-104
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPYno. 3 (2024): 567-577
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases (2024)
ANTIMICROBIAL AGENTS AND CHEMOTHERAPYno. 1 (2024): e0120123-e0120123
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn